Good MorningEquity markets slipped on Thursday following a round of weaker-than-expected data. While the rise in jobless claims, the shortfall in the Philly Fed MBOS, and weaker-than-expected housing data suggest softening in the economy, none were truly bearish. Jobless claims are trending at healthy levels, the Philly Fed MBOS points to economic expansion, and housing data aligns with trends. The question is whether the trends will remain in place while the FOMC waits for inflation to cool or if the economy will tip into a recession. However, the odds of a recession are low, so the market should continue to climb its wall of worry.
The next big hurdle for markets won't come until next Friday. The May read on income, spending, and consumer inflation is due and expected to align with the recent CPI data. The CPI shows inflation cooling but at a slow pace, which is unlikely to allow the FOMC to cut rates before November or at the pace markets have priced in. However, if the data aligns with cooling inflation and an FOMC pivot to lower rates, the market rally will likely continue. Featured: Protect Your Bank Account Before It's Too Late (Weiss Ratings) 
|
Markets | | | Investors can often dissect the reasoning behind some of the world's brightest minds' choices, remembering not to blindly follow them. The investing world is always focused on what mega investors like Warren Buffett or Ray Dalio have been buying or selling lately; however, other gems in other area... Read the Full Story >> |
|
From Our PartnersAfter Nvidia's record-breaking earnings surge, Wall Street is now selling the stock at the fastest pace in seven months.
So if you currently own NVIDIA (NVDA)... Or were thinking of buying it in the weeks ahead...
I urge you to review my recent interview with 50-year Wall Street legend Marc Chaikin. | | | | You can watch it here. |
|
Markets | | | The renewable energy sector is experiencing unprecedented growth, a trend reflected in the record-breaking 2023 installation of 305 gigawatts (GW) of new solar capacity worldwide. This surge signifies a global shift towards cleaner energy sources, with solar and wind power playing a central role i... Read the Full Story >> |
|
Tech | | | Gilead Sciences (NASDAQ: GILD) saw its stock jump nearly 10% yesterday after announcing groundbreaking results from its HIV treatment trial. The biopharmaceutical company revealed 100% efficacy in its Phase 3 HIV prevention trial, marking the first trial showing zero infections. Given the s... Read the Full Story >> |
|
From Our PartnersCould Elon's New Device be Bigger than the iPhone?
According to 30-year Silicon Valley and Wall Street veteran, Eric Fry…
This mind-blowing new technology could be bigger than the iPhone. | | | | Click here for the full story… |
|
Stocks | | | U.S. stocks coasted to the close of their latest winning week on Friday, as Nvidia 's stock continued to cool from its startling, supernova run.The S&P 500 slipped 0.2%, but it remained close to its all-time high set on Tuesday and capped its eighth winning week in the last nine. The Dow Jones I... Read the Full Story >> |
|
Markets | | | CarMax (NYSE: KMX) is set up for a market melt-up because of improving market sentiment. The used car market is still struggling due to market normalization, but it is sufficient to drive solid cash flow for this business, and the trends are improving. The critical takeaway from the Q1 report is t... Read the Full Story >> |
|
|
Markets | | | Japan's exports surged 13.5% in May, faster than expected growth helped by a weak yen and strong demand in the U.S. and Asia. Finance Ministry data reported Wednesday showed that the trade deficit totaled 1.22 trillion yen ($7.7 billion), down nearly 12% from 1.38 trillion yen a year earlier. Import... Read the Full Story >> |
|
Markets | | | World stocks were mixed on Wednesday after U.S. benchmarks ticked to more records following the latest signs that the U.S. economy may be slowing without falling into recession.The future for the Dow Jones Industrial Average was down 0.1% while that for the S&P 500 rose 0.1%. U.S. markets are cl... Read the Full Story >> |
|
Markets | | | Sarepta Therapeutics (NASDAQ: SRPT) is leading the game in precision genetic medicine and biotechnology. Sarepta Therapeutics' stock price has witnessed a surge of over 40% after receiving expanded FDA approval for its Duchenne muscular dystrophy (DMD) gene therapy, Elevidys. This pivotal decisi... Read the Full Story >> |
|
Markets | | | The Bank of England on Thursday kept its main interest rate at a 16-year high of 5.25% even though inflation has fallen to its target of 2%, with several policymakers warning that a premature cut could stoke another bout of price rises.For the second meeting in a row, seven of the nine members of th... Read the Full Story >> |
|
Markets | | | Apple is discontinuing its buy now, pay later service known as Apple Pay Later barely a year after its initial launch in the U.S., and will rely on companies who already dominate the industry like Affirm and Klarna Read the Full Story >> |
|
No comments:
Post a Comment